{"entity":{"type":"insider","cik":"0001639978","url":"/insider/0001639978","json_url":"/insider/0001639978.json","name":"Mathers Thomas P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":10,"first":"2015-08-25","last":"2017-01-05","span_basis":"filed_date"},"name_variants":[{"name":"Mathers Thomas P.","source":"filing","n_filings":10,"first_seen":"2015-08-25","last_seen":"2017-01-05"}],"transactions":[{"id":5052685,"accession":"0000911916-17-000034","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000911916-17-000034","line_url":"/filing/0000911916-17-000034","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":34.77892969374168,"price_display":"34.78","price_state":"stated","total_value":52237.9524,"total_display":"52,237.95","total_whole":"52,238","shares_owned_after":257219.0,"shares_owned_after_display":"257,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-05","filed_date":"2017-01-05","scope":"insider","n_lines":3},{"id":3241080,"accession":"0000911916-16-000701","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000701","line_url":"/filing/0000911916-16-000701#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":38.75,"price_display":"38.75","price_state":"stated","total_value":58202.5,"total_display":"58,202.50","total_whole":"58,203","shares_owned_after":254266.0,"shares_owned_after_display":"254,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-05","filed_date":"2016-12-05","scope":"insider"},{"id":2236297,"accession":"0000911916-16-000691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000691","line_url":"/filing/0000911916-16-000691#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":28.5732,"price_display":"28.57","price_state":"stated","total_value":42916.9464,"total_display":"42,916.95","total_whole":"42,917","shares_owned_after":248920.0,"shares_owned_after_display":"248,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-07","filed_date":"2016-11-07","scope":"insider"},{"id":2863761,"accession":"0000911916-16-000680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000680","line_url":"/filing/0000911916-16-000680#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":37.08,"price_display":"37.08","price_state":"stated","total_value":55694.16,"total_display":"55,694.16","total_whole":"55,694","shares_owned_after":246667.0,"shares_owned_after_display":"246,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-05","filed_date":"2016-10-05","scope":"insider"},{"id":2080565,"accession":"0000911916-16-000658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000658","line_url":"/filing/0000911916-16-000658","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":23.32438,"price_display":"23.32","price_state":"stated","total_value":139946.28,"total_display":"139,946.28","total_whole":"139,946","shares_owned_after":244714.0,"shares_owned_after_display":"244,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-16","scope":"insider","n_lines":2},{"id":3200835,"accession":"0000911916-16-000652","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000911916-16-000652","line_url":"/filing/0000911916-16-000652","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":22.38460362,"price_display":"22.38","price_state":"stated","total_value":111923.0181,"total_display":"111,923.02","total_whole":"111,923","shares_owned_after":251156.0,"shares_owned_after_display":"251,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-07","filed_date":"2016-09-07","scope":"insider","n_lines":5},{"id":3200824,"accession":"0000911916-16-000652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000652","line_url":"/filing/0000911916-16-000652#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":29289.0,"total_display":"29,289.00","total_whole":"29,289","shares_owned_after":255414.0,"shares_owned_after_display":"255,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-06","filed_date":"2016-09-07","scope":"insider"},{"id":2162184,"accession":"0000911916-16-000638","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000638","line_url":"/filing/0000911916-16-000638#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":8.31,"price_display":"8.31","price_state":"stated","total_value":12481.62,"total_display":"12,481.62","total_whole":"12,482","shares_owned_after":253160.0,"shares_owned_after_display":"253,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-05","filed_date":"2016-08-05","scope":"insider"},{"id":2311418,"accession":"0000911916-16-000624","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000624","line_url":"/filing/0000911916-16-000624#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":9.73,"price_display":"9.73","price_state":"stated","total_value":14614.46,"total_display":"14,614.46","total_whole":"14,614","shares_owned_after":250907.0,"shares_owned_after_display":"250,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-05","scope":"insider"},{"id":2417511,"accession":"0000911916-16-000579","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000579","line_url":"/filing/0000911916-16-000579#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":7.2463,"price_display":"7.25","price_state":"stated","total_value":10883.9426,"total_display":"10,883.94","total_whole":"10,884","shares_owned_after":248654.0,"shares_owned_after_display":"248,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-07","scope":"insider"},{"id":8170927,"accession":"0000911916-15-000316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-15-000316","line_url":"/filing/0000911916-15-000316#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639978","owner_name":"Mathers Thomas P.","owner_display_name":"Mathers Thomas P.","owner_url":"/insider/0001639978","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":7.1033,"price_display":"7.10","price_state":"stated","total_value":53274.75,"total_display":"53,274.75","total_whole":"53,275","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-25","filed_date":"2015-08-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348649","name":"CoLucid Pharmaceuticals, Inc.","url":"/issuer/0001348649","role":"Director, Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2015-08-25","last_seen":"2017-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001639978","retrieved_at":"2026-08-26T11:03:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}